Microsampling Approach for Monitoring of Kinase Inhibitor Targeted Therapies

Clinical trial NCT05598788 · COMPLETED

Trial details

NCT number: NCT05598788
Sponsor: Rennes University Hospital
Status: COMPLETED
Study type: OBSERVATIONAL

Blood Concentrations of Nine Anti-cancer Drugs : Axitinib, Olaparib, regorafénib, Cabozantinib, Niraparib, Talazoparib, Palbociclib, Abemaciclib, Tucatinib

Start date: 2023-03-03
Primary completion: 2025-04-24
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.